Continuous Glucose Monitoring in Infants
ConditionNeonatal Hypoglycemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-2
SponsorUniversity of California, San Diego
About this trial
The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.
Eligibility criteria
Qualifiers
Mother at least 18 years of age
Infants born either appropriate for gestational age (AGA) or large for gestational age (LGA)
Skin fold over superior gluteus area at least 1 inch in thickness as measured by skin calipers
Disqualifiers
Infants born small for gestational age (SGA)
Infant birth weight <2.5 kg
Infant BMI <10th percentile on Olsen chart
Infants born <38 weeks gestation
Trial design
Treatments tested in this trial
- Dexcom continuous glucose monitor
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of California, San Diego
Lead sponsor
DexCom, Inc.
Collaborator
Source ClinicalTrials.gov